[1] |
GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet Neurol, 2021, 20(10): 795-820.
doi: 10.1016/S1474-4422(21)00252-0
pmid: 34487721
|
[2] |
KIM J, THAYABARANATHAN T, DONNAN G A, et al. Global Stroke Statistics 2019[J]. Int J Stroke, 2020, 15(8): 819-838.
doi: 10.1177/1747493020909545
|
[3] |
LIN D H, ZHANG X R, YE D Q, et al. The role of the two-pore domain potassium channel Trek-1 in the therapeutic effects of escitalopram in a rat model of poststroke depression[J]. CNS Neurosci Ther, 2015, 21(6): 504-512.
doi: 10.1111/cns.12384
|
[4] |
TAO X, YANG W, ZHU S, et al. Models of poststroke depression and assessments of core depressive symptoms in rodents: how to choose?[J]. Exp Neurol, 2019, 322(12): 113060.
|
[5] |
YI Z M, LIU F, ZHAI S D. Fluoxetine for the prophylaxis of poststroke depression in patients with stroke: a meta-analysis[J]. Int J Clin Pract, 2010, 64(9): 1310-1317.
doi: 10.1111/j.1742-1241.2010.02437.x
pmid: 20653802
|
[6] |
ZHU J, PENG Q, XU Y, et al. Morinda officinalis oligosaccharides ameliorate depressive-like behaviors in poststroke rats through upregulating GLUT3 to improve synaptic activity[J]. FASEB J, 2020, 34(10): 13376-13395.
doi: 10.1096/fj.201902546RR
|
[7] |
DAS J, G K R. Post stroke depression: the sequelae of cerebral stroke[J]. Neurosci Biobehav Rev, 2018, 90(7): 104-114.
doi: 10.1016/j.neubiorev.2018.04.005
|
[8] |
HU Z C, WU Y C, WANG N H. Clinical study on acupuncture treatment of post-stroke depression in recent ten years[J]. J Acupunct Tuina Sci, 2011, 9(5): 324-330.
doi: 10.1007/s11726-011-0544-y
|
[9] |
杨文君, 张晓燕. 卒中后抑郁的非药物治疗研究进展[J]. 四川精神卫生, 2022, 35(5): 471-476.
|
|
YANG W J, ZHANG X Y. Research progress on non-pharmacological therapies for post-stroke depression[J]. Sichuan Mental Health, 2022, 35(5): 471-476.
|
[10] |
谢晓彬, 陈雅敏, 张卫. 近5年针灸治疗卒中后抑郁的研究进展[J]. 中医临床研究, 2022, 14(16): 142-145.
|
|
XIAO X B, CHEN Y M, ZHANG W. A review on treating post-stroke depression by acupuncture and moxibustion in recent 5 years[J]. Clin J Chin Med, 2022, 14(16): 142-145.
|
[11] |
LONGA E Z, WEINSTEIN P R, CARLSON S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats[J]. Stroke, 1989, 20(1): 84-91.
doi: 10.1161/01.str.20.1.84
pmid: 2643202
|
[12] |
闫咏梅, 柯婷, 范文涛, 等. 醒脑解郁方对卒中后抑郁症模型大鼠行为学及海马区p-ERK1/2的影响[J]. 中国中西医结合杂志, 2018, 38(4): 447-452.
|
|
YAN Y M, KE T, FAN W T, et al. Effect of Xingnao Jieyu Recipe on behavioral and hippocampus p-ERK1/2 in post-stroke depression model rats[J]. Chin J Integr Trad West Med, 2018, 38(4): 447-452.
|
[13] |
李忠仁. 实验针灸学[M]. 北京: 中国中医药出版社, 2007: 242.
|
|
LI Z R. Experimental acupuncture science[M]. Beijing: China Press of Traditional Chinese Medicine, 2007: 242.
|
[14] |
IFERGANE G, BOYKO M, FRANK D, et al. Biological and behavioral patterns of post-stroke depression in rats[J]. Can J Neurol Sci, 2018, 45(4): 451-461.
doi: 10.1017/cjn.2017.302
pmid: 29880078
|
[15] |
POHJASVAARA T, VATAJA R, LEPPÄVUORI A, et al. Suicidal ideas in stroke patients 3 and 15 months after stroke[J]. Cerebrovasc Dis, 2001, 12(1): 21-26.
doi: 10.1159/000047676
pmid: 11435675
|
[16] |
EDWARDS JD, KAPOOR A, LINKEWICH E, et al. Return to work after young stroke: a systematic review[J]. Int J Stroke, 2018, 13(3): 243-256.
doi: 10.1177/1747493017743059
pmid: 29189108
|
[17] |
VESTLING M, TUFVESSON B, IWARSSON S. Indicators for return to work after stroke and the importance of work for subjective well-being and life satisfaction[J]. J Rehabil Med, 2003, 35(3): 127-131.
doi: 10.1080/16501970310010475
pmid: 12809195
|
[18] |
WESTERLIND E, PERSSON H C, PALSTAM A, et al. Differences in self-perceived general health, pain, and depression 1 to 5 years post-stroke related to work status at 1 year[J]. Sci Rep, 2020, 10(1): 13251.
doi: 10.1038/s41598-020-70228-2
|
[19] |
FANG J, CHEN L, MA R, et al. Comprehensive rehabilitation with integrative medicine for subacute stroke: a multicenter randomized controlled trial[J]. Sci Rep, 2016, 6(1): 25850.
doi: 10.1038/srep25850
|
[20] |
潘美伯, 王玢, 王慧, 等. 大鼠卒中后抑郁模型评价的网状Meta分析[J]. 实验动物科学, 2022, 39(2): 65-74.
|
|
PAN M B, WANG B, WANG H, et al. A network meta-analysis of the evaluation of post-stroke depression models in rats[J]. Lab Anim Sci, 2022, 39(2): 65-74.
|
[21] |
MARTIN A L, BROWN R E. The lonely mouse: verification of a separation-induced model of depression in female mice[J]. Behav Brain Res, 2010, 207(1): 196-207.
doi: 10.1016/j.bbr.2009.10.006
pmid: 19819265
|
[22] |
WANG J M, YANG L H, ZHANG Y Y, et al. BDNF and COX-2 participate in anti-depressive mechanisms of catalpol in rats undergoing chronic unpredictable mild stress[J]. Physiol Behav, 2015, 151(1): 360-368.
doi: 10.1016/j.physbeh.2015.08.008
|
[23] |
王雪, 杨栋婷, 刘文娜, 等. 基于复杂网络分析的针刺治疗脑卒中后抑郁的俞穴配伍规律研究[J]. 中国医药导报, 2019, 16(33): 111-115.
|
|
WANG X, YANG D T, LIU W N, et al. Study on the general character of acupuncture points for post-stroke depression based on complex network analysis[J]. Chin Med Herald, 2019, 16(33): 111-115.
|
[24] |
陈波, 李明月, 赵雪, 等. 基于文献数据挖掘技术的腧穴配伍规律研究进展[J]. 辽宁中医杂志, 2018, 45(3): 654-656.
|
|
CHEN B, LI M Y, ZHAO X, et al. Bibliographic data digging research based on progress of rules of acupoints combination[J]. Liaoning J Tradit Chin Med, 2018, 45(3): 654-656.
|
[25] |
冯勇, 肖慧玲, 林仁勇, 等. 薄氏腹针治疗中风后抑郁症临床疗效观察[J]. 针灸临床杂志, 2011, 27(10): 33-35.
|
|
FENG Y, XIAO H L, LIN R Y, et al. Bo's abdominal acupuncture in the treatment of depression after stroke[J]. J Clin Acupunct Moxibust, 2011, 27(10): 33-35.
|
[26] |
SUN X, ZHANG T, ZHAO Y, et al. Panaxynol attenuates CUMS-induced anxiety and depressive-like behaviors via regulating neurotransmitters, synapses and the HPA axis in mice[J]. Food Funct, 2020, 11(2): 1235-1244.
doi: 10.1039/c9fo03104a
pmid: 32048672
|
[27] |
李润霞, 张峥, 刘艳清, 等. 疏肝解郁胶囊联合个性化愉悦元素积极刺激干预对脑卒中后抑郁患者5-HT、NE、DA的影响[J]. 辽宁中医杂志, 2021, 48(4): 122-126.
|
|
LI R X, ZHANG Z, LIU Y Q, et al. Effects of ShuganJieyu capsule and personalized pleasure elements intervention on 5-HT, NE and DA in Patients with post-stroke depression[J]. Liaoning J Tradit Chin Med, 2021, 48(4): 122-126.
|
[28] |
KIM J M, KANG H J, KIM J W, et al. Associations of tumor necrosis factor-α and interleukin-1β levels and polymorphisms with post-stroke depression[J]. Am J Geriatr Psychiatry, 2017, 25(12): 1300-1308.
doi: 10.1016/j.jagp.2017.07.012
|
[29] |
赵昌东, 赵红艳, 柯希权, 等. 焦虑与抑郁心理对溃疡性结肠炎患者神经内分泌免疫的影响研究[J]. 中国全科医学, 2020, 23(2): 234-239.
doi: 10.12114/j.issn.1007-9572.2019.00.318
|
|
ZHAO C D, ZHAO H Y, KE X Q, et al. Effects of anxiety and depression on neuroendocrine immune network in patients with ulcerative colitis[J]. Chin Gener Pract, 2020, 23(2): 234-239.
|
[30] |
RYBKA J, KORTE S M, CZAJKOWSKA-MALINOWSKA M, et al. The links between chronic obstructive pulmonary disease and comorbid depressive symptoms: role of IL-2 and IFN-γ[J]. Clin Exp Med. 2016, 16(4): 493-502.
pmid: 26403459
|
[31] |
刘淑英. 卒中单元模式下醒神启闭针刺治疗卒中后抑郁疗效观察及对血清Th型细胞因子的影响[J]. 上海针灸杂志, 2022, 41(1): 35-42.
|
|
LIU S Y. Efficacy observation of Xing Shen Qi Bi Acupuncture for post-stroke depression in a stroke unit model and its effects on serum Th cytokines[J]. Shanghai J Acupunct Moxibust, 2022, 41(1): 35-42.
|
[32] |
RAISON C L, CAPURON L, MILLER A H. Cytokines sing the blues: inflammation and the pathogenesis of depression[J]. Trends Immunol, 2006, 27(1): 24-31.
doi: 10.1016/j.it.2005.11.006
pmid: 16316783
|
[33] |
徐倩倩, 钱旭东, 孙凡, 等. 老年脑卒中后抑郁水平与5-HT、炎性因子和BDNF水平的关系[J]. 分子诊断与治疗杂志, 2022, 14(6): 1004-1007.
|
|
XU Q Q, QIAN X D, SUN F, et al. The relationship between depression level and levels of 5-HT, inflammatory factors and BDNF in the elderly after stroke[J]. J Molecul Diagnost Therapy, 2022, 14(6): 1004-1007.
|
[34] |
岳亚敏, 乔柏. 卒中后抑郁与血清炎性细胞因子水平及神经功能损害的相关性[J]. 中国健康心理学杂志, 2018: 26(11): 1638-1642.
|
|
YUE Y M, QIAO B. Correlation analysis of post-stroke depression with serum inflammatory cytokine level and nerve function impairment[J]. Chin J Health Psychol, 2018: 26(11): 1638-1642.
|
[35] |
CALANDRA T, ROGER T. Macrophage migration inhibitory factor: a regulator of innate immunity[J]. Nat Rev Immunol, 2003, 3(10): 791-800.
doi: 10.1038/nri1200
pmid: 14502271
|
[36] |
IRWIN M R, MILLER A H. Depressive disorders and immunity: 20 years of progress and discovery[J]. Brain Behav Immun, 2007, 21(4): 374-383.
doi: 10.1016/j.bbi.2007.01.010
pmid: 17360153
|
[37] |
BAY-RICHTER C, JANELIDZE S, SAURO A, et al. Behavioural and neurobiological consequences of macrophage migration inhibitory factor gene deletion in mice[J]. J Neuroinflam, 2015, 12(1): 163.
doi: 10.1186/s12974-015-0387-4
|
[38] |
XU T, PU S, NI Y, et al. Elevated plasma macrophage migration inhibitor factor as a risk factor for the development of post-stroke depression in ischemic stroke[J]. J Neuroimmunol, 2018, 320(7): 58-63.
doi: 10.1016/j.jneuroim.2018.04.003
|